Patents by Inventor Yaping Zhu

Yaping Zhu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulated release particles for lung delivery
    Publication number: 20020110539
    Abstract: A polymeric construct is disclosed. The construct comprises a polysaccharide polymer having a selected medicament associated therewith. The medicament thus present is provided in a slow release form.
    Type: Application
    Filed: February 15, 2001
    Publication date: August 15, 2002
    Inventors: Yaping Zhu, Simon G. Stefanos, Lukeysha Kline, Akwete L. Adjei
  • Core formulation
    Patent number: 6403121
    Abstract: This invention relates to a modulating formulation comprising pioglitazone hydrochloride and a biguamide, e.g. metformin. In particular, the product comprises a core of the biguamide, e.g. metformin, at least a portion thereof has a layer or coat thereon of pioglitazone.
    Type: Grant
    Filed: February 15, 2001
    Date of Patent: June 11, 2002
    Assignee: Aeropharm Technology Incorporated
    Inventors: Akwete L. Adjei, Yaping Zhu, Anthony J. Cutie
  • Core formulation
    Publication number: 20010046515
    Abstract: This invention relates to a modulating formulation comprising pioglitazone hydrochloride and a biguamide, e.g. metformin. In particular, the product comprises a core of the biguamide, e.g. metformin, at least a portion thereof has a layer or coat thereon of pioglitazone.
    Type: Application
    Filed: February 15, 2001
    Publication date: November 29, 2001
    Inventors: Akwete L. Adjei, Yaping Zhu, Anthony J. Cutie
  • Core formulation
    Publication number: 20010036478
    Abstract: This invention relates to a controlled-release combination drug product comprising troglitazone, e.g. its hydrochloride, and a biguamide, e.g. metformin. In particular, the product comprises a core of metformin, at least a portion thereof has a layer or coat thereon of troglitazone.
    Type: Application
    Filed: February 15, 2001
    Publication date: November 1, 2001
    Inventors: Akwete L. Adjei, Yaping Zhu, Anthony J. Cutie
  • Core formulation
    Publication number: 20010034374
    Abstract: This invention relates to a controlled release combination drug product comprising troglitazone, e.g. its hydrochloride, and a biguamide, e.g. metformin. In particular, the product comprises a core of metformin, at least a portion thereof has a layer or coat thereon of troglitazone.
    Type: Application
    Filed: February 15, 2001
    Publication date: October 25, 2001
    Inventors: Akwete L. Adjei, Yaping Zhu, Anthony J. Cutie